Home2024-08-22T17:00:45+02:00

Unleash the full potential of mRNA with the All-ScaleFlow™ technology

We are developing cutting-edge equipment to enhance global healthcare access by simplifying and improving the production of mRNA vaccines and therapies.

A REVOLUTIONARY APPROACH WITH A GAME-CHANGING TECHNOLOGY

All-ScaleFlow™-based-equipment allows to produce mRNA vaccines and therapeutics faster, all over the world, at any scale!

0

Doses
Minimum scale

0M

Doses
Annual capacity

0m²

Only
Equipment footprint

Industry professionals encounter many challenges in producing mRNA-based-therapeutics.

The COVID-19 pandemic revealed the limits of multi-step batch production for vaccines, highlighting the need for new approaches. The future now belongs to continuous & automated mRNA manufacturing processes.

Industry professionals encounter many challenges in producing mRNA-based-therapeutics.

The COVID-19 pandemic revealed the limits of multi-step batch production for vaccines, highlighting the need for new approaches. The future now belongs to continuous & automated mRNA manufacturing processes.

FROM EARLY DEVELOPMENT TO COMMERCIAL MANUFACTURING

All-ScaleFlow™-based-equipment removes major industrial roadblocks in the production of mRNA-LNP

FROM EARLY DEVELOPMENT TO COMMERCIAL MANUFACTURING

All-ScaleFlow™-based-equipment

removes major industrial roadblocks in the production of mRNA-LNP

PARTNERS

They trust us

NEWS

Welcome!

We are pleased to welcome you to our new website. Until now, Dillico has remained very discreet, focusing on exchanges with the main players in the mRNA field - we are now entering [...]

15 January 2023|
Read More

Headquarters